143 related articles for article (PubMed ID: 15318934)
1. Chromosomal instability and lack of cyclin E regulation in hCdc4 mutant human breast cancer cells.
Willmarth NE; Albertson DG; Ethier SP
Breast Cancer Res; 2004; 6(5):R531-9. PubMed ID: 15318934
[TBL] [Abstract][Full Text] [Related]
2. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line.
Strohmaier H; Spruck CH; Kaiser P; Won KA; Sangfelt O; Reed SI
Nature; 2001 Sep; 413(6853):316-22. PubMed ID: 11565034
[TBL] [Abstract][Full Text] [Related]
3. FBXW7 and DNA copy number instability.
Byrd KN; Huey B; Roydasgupta R; Fridlyand J; Snijders AM; Albertson DG
Breast Cancer Res Treat; 2008 May; 109(1):47-54. PubMed ID: 17588203
[TBL] [Abstract][Full Text] [Related]
4. Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer.
Ekholm-Reed S; Spruck CH; Sangfelt O; van Drogen F; Mueller-Holzner E; Widschwendter M; Zetterberg A; Reed SI
Cancer Res; 2004 Feb; 64(3):795-800. PubMed ID: 14871801
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of hCDC4 can cause chromosomal instability.
Rajagopalan H; Jallepalli PV; Rago C; Velculescu VE; Kinzler KW; Vogelstein B; Lengauer C
Nature; 2004 Mar; 428(6978):77-81. PubMed ID: 14999283
[TBL] [Abstract][Full Text] [Related]
6. MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression.
Lerner M; Lundgren J; Akhoondi S; Jahn A; Ng HF; Akbari Moqadam F; Oude Vrielink JA; Agami R; Den Boer ML; Grandér D; Sangfelt O
Cell Cycle; 2011 Jul; 10(13):2172-83. PubMed ID: 21597324
[TBL] [Abstract][Full Text] [Related]
7. FBW7 Loss Promotes Chromosomal Instability and Tumorigenesis via Cyclin E1/CDK2-Mediated Phosphorylation of CENP-A.
Takada M; Zhang W; Suzuki A; Kuroda TS; Yu Z; Inuzuka H; Gao D; Wan L; Zhuang M; Hu L; Zhai B; Fry CJ; Bloom K; Li G; Karpen GH; Wei W; Zhang Q
Cancer Res; 2017 Sep; 77(18):4881-4893. PubMed ID: 28760857
[TBL] [Abstract][Full Text] [Related]
8. Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma.
Cassia R; Moreno-Bueno G; Rodríguez-Perales S; Hardisson D; Cigudosa JC; Palacios J
J Pathol; 2003 Dec; 201(4):589-95. PubMed ID: 14648662
[TBL] [Abstract][Full Text] [Related]
9. Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes.
Yu JC; Ding SL; Chang CH; Kuo SH; Chen ST; Hsu GC; Hsu HM; Hou MF; Jung LY; Cheng CW; Wu PE; Shen CY
Carcinogenesis; 2009 Sep; 30(9):1562-70. PubMed ID: 19587092
[TBL] [Abstract][Full Text] [Related]
10. hCDC4 gene mutations in endometrial cancer.
Spruck CH; Strohmaier H; Sangfelt O; Müller HM; Hubalek M; Müller-Holzner E; Marth C; Widschwendter M; Reed SI
Cancer Res; 2002 Aug; 62(16):4535-9. PubMed ID: 12183400
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitylation of cyclin E requires the sequential function of SCF complexes containing distinct hCdc4 isoforms.
van Drogen F; Sangfelt O; Malyukova A; Matskova L; Yeh E; Means AR; Reed SI
Mol Cell; 2006 Jul; 23(1):37-48. PubMed ID: 16818231
[TBL] [Abstract][Full Text] [Related]
12. Cyclin E dysregulation and chromosomal instability in endometrial cancer.
Hubalek MM; Widschwendter A; Erdel M; Gschwendtner A; Fiegl HM; Müller HM; Goebel G; Mueller-Holzner E; Marth C; Spruck CH; Reed SI; Widschwendter M
Oncogene; 2004 May; 23(23):4187-92. PubMed ID: 15048079
[TBL] [Abstract][Full Text] [Related]
13. SCF(Fbxw7/hCdc4) targets cyclin E2 for ubiquitin-dependent proteolysis.
Klotz K; Cepeda D; Tan Y; Sun D; Sangfelt O; Spruck C
Exp Cell Res; 2009 Jul; 315(11):1832-9. PubMed ID: 19084516
[TBL] [Abstract][Full Text] [Related]
14. Regulation of neddylation and deneddylation of cullin1 in SCFSkp2 ubiquitin ligase by F-box protein and substrate.
Bornstein G; Ganoth D; Hershko A
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11515-20. PubMed ID: 16861300
[TBL] [Abstract][Full Text] [Related]
15. High copy amplification of the Aurora-A gene is associated with chromosomal instability phenotype in human colorectal cancers.
Nishida N; Nagasaka T; Kashiwagi K; Boland CR; Goel A
Cancer Biol Ther; 2007 Apr; 6(4):525-33. PubMed ID: 17457043
[TBL] [Abstract][Full Text] [Related]
16. Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells.
Caldon CE; Sergio CM; Sutherland RL; Musgrove EA
Cell Cycle; 2013 Feb; 12(4):596-605. PubMed ID: 23324394
[TBL] [Abstract][Full Text] [Related]
17. Depletion of SUMO ligase hMMS21 impairs G1 to S transition in MCF-7 breast cancer cells.
Ni HJ; Chang YN; Kao PH; Chai SP; Hsieh YH; Wang DH; Fong JC
Biochim Biophys Acta; 2012 Dec; 1820(12):1893-900. PubMed ID: 22906975
[TBL] [Abstract][Full Text] [Related]
18. Triggering ubiquitination of a CDK inhibitor at origins of DNA replication.
Furstenthal L; Swanson C; Kaiser BK; Eldridge AG; Jackson PK
Nat Cell Biol; 2001 Aug; 3(8):715-22. PubMed ID: 11483956
[TBL] [Abstract][Full Text] [Related]
19. The growth arrest function of the human oncoprotein mouse double minute-2 is disabled by downstream mutation in cancer cells.
Zhou R; Frum R; Deb S; Deb SP
Cancer Res; 2005 Mar; 65(5):1839-48. PubMed ID: 15753382
[TBL] [Abstract][Full Text] [Related]
20. Deregulated cyclin E induces chromosome instability.
Spruck CH; Won KA; Reed SI
Nature; 1999 Sep; 401(6750):297-300. PubMed ID: 10499591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
